Specialty Pharmacy

Excess medical expenses, employment disability, and a drop in production at work common in cancer survivors.

Promising results from generic formulation of drug used post-transplant to reduce the risk of organ rejection.

Study warns that drug reviewers don't look at long term survival of patients.

Investigational 3-drug combination cleared the virus in 93% of treatment-naïve patients.

Particles protected antigen from premature destruction and prompted the immune system to attack cancer cells.

The FDA is actively investigating vulnerabilities identified in Hospira's LifeCare PCA3 and PCA5 infusion pump systems.

Direct-acting-antiviral drugs daclatasvir, asunaprevir, and beclabuvir showed high rates of sustained virologic response after 12 weeks.

Age and weight found to play a role in side effects.

Regular trips to the emergency department could be a red flag for deadly prescription drug overdose.

Kjel Jonhson, PharmD, Vice President of Global Oncology for IMS Health, discusses changes in store for the care of cancer patients over the next decade.

Mass spectrometry reveals all proteins that repair damaged cancer DNA.

Targeting gene mutations causes stress that damages cancer cell DNA.

Many consultant pharmacists are taking on new roles and responsibilities in the shifting long-term care landscape, allowing them to perform a number of enhanced services.

Treating immune-suppressing cells allows for destruction of tumors.

Study finds chronic hepatitis C has a limited impact on mortality unless the patient has other severe comorbidities.

Washington State Governor Jay Inslee signed into law on May 11, 2015, a bill that makes Washington the first state in the country to require that pharmacists are included in health insurance provider networks.

Even healthy adults taking statins are 87% more likely to develop diabetes.

Liver damage is the bane of HIV-infected patients' existence.

Veterans Affairs covers few compounded medications through pharmacies and via mail order.

A look back at the top stories on Specialty Pharmacy Times from May 4 to May 8.

Implant delivers sustained release of ARV drugs up to 40 days with no adverse side effects.

Genetically determined telomere length may not influence mortality.

Combination of recombinant factor VIII with a fusion protein allows for less frequent treatment.

Diets with more animal protein and less soluble fiber increases cancer risk.

Researchers find significant reduction in lung cancer-specific deaths.

Teva is voluntarily recalling select lots of intravenous fluorouracil (Adrucil).

Patients with AIDS face a 4-fold greater risk of age-related macular degeneration (AMD) than their HIV-uninfected counterparts.

Cancer rates significantly greater compared with non-infected individuals.

Mitra Habibi, PharmD, a clinical pharmacist at the University of Illinois Hospital and Health Sciences System, discusses the elements of an optimal program for monitoring patients with multiple sclerosis to ensure adherence.

Boosting immune system improves efficacy of antiretroviral drugs.